ウイルスベクター・プラスミドDNAの世界市場 2020年：企業別、地域別、種類・用途別

• レポートコード： • 出版社/出版日： / • レポート形態：、、ページ数はお問い合わせください。 • 納品方法：

• 販売価格（消費税別）

￥ 日本円の価格はお問い合わせください。 (0)

▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Market Overview
The Viral Vector and Plasmid DNA market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Viral Vector and Plasmid DNA sales will be xx in 2020 from Viral Vector and Plasmid DNA million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Viral Vector and Plasmid DNA market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Viral Vector and Plasmid DNA industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Viral Vector and Plasmid DNA and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Viral Vector and Plasmid DNA market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Viral Vector and Plasmid DNA market has been segmented into:
Plasmid DNA
Viral Vector

By Application, Viral Vector and Plasmid DNA has been segmented into:
Cancer
Virus Infection
Hereditary Disease

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Viral Vector and Plasmid DNA market presented in the report. This section sheds light on the sales growth of different regional and country-level Viral Vector and Plasmid DNA markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Viral Vector and Plasmid DNA market.

The report offers in-depth assessment of the growth and other aspects of the Viral Vector and Plasmid DNA market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Viral Vector and Plasmid DNA Market Share Analysis
Viral Vector and Plasmid DNA competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Viral Vector and Plasmid DNA sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Viral Vector and Plasmid DNA sales, revenue and market share for each player covered in this report.

The major players covered in Viral Vector and Plasmid DNA are:
Brammer Bio
FUJIFILM Diosynth Biotechnologies
FinVector
Oxford BioMedica
MolMed
Cobra Biologics
Aldevron
BioReliance
Lonza
UniQure
Cell and Gene Therapy Catapult
VGXI
Richter-Helm
PlasmidFactory
MassBiologics
Yposkesi
Eurogentec
Gene Synthesis
Biovian
OBiO Technology
Jikai Gene
Among other players domestic and global, Viral Vector and Plasmid DNA market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 Viral Vector and Plasmid DNA Market Overview
1.1 Product Overview and Scope of Viral Vector and Plasmid DNA
1.2 Classification of Viral Vector and Plasmid DNA by Type
1.2.1 Global Viral Vector and Plasmid DNA Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Type in 2019
1.2.3 Plasmid DNA
1.2.4 Viral Vector
1.3 Global Viral Vector and Plasmid DNA Market by Application
1.3.1 Overview: Global Viral Vector and Plasmid DNA Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Virus Infection
1.3.4 Hereditary Disease
1.4 Global Viral Vector and Plasmid DNA Market by Regions
1.4.1 Global Viral Vector and Plasmid DNA Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Viral Vector and Plasmid DNA (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Viral Vector and Plasmid DNA Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Viral Vector and Plasmid DNA Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Vector and Plasmid DNA Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Viral Vector and Plasmid DNA Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Vector and Plasmid DNA Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Viral Vector and Plasmid DNA Industry Impact
1.5.1 COVID-19 Potential Implications for the Viral Vector and Plasmid DNA
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Viral Vector and Plasmid DNA
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Brammer Bio
2.1.1 Brammer Bio Details
2.1.2 Brammer Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Brammer Bio SWOT Analysis
2.1.4 Brammer Bio Product and Services
2.1.5 Brammer Bio Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.2 FUJIFILM Diosynth Biotechnologies
2.2.1 FUJIFILM Diosynth Biotechnologies Details
2.2.2 FUJIFILM Diosynth Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 FUJIFILM Diosynth Biotechnologies SWOT Analysis
2.2.4 FUJIFILM Diosynth Biotechnologies Product and Services
2.2.5 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.3 FinVector
2.3.1 FinVector Details
2.3.2 FinVector Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 FinVector SWOT Analysis
2.3.4 FinVector Product and Services
2.3.5 FinVector Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.4 Oxford BioMedica
2.4.1 Oxford BioMedica Details
2.4.2 Oxford BioMedica Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Oxford BioMedica SWOT Analysis
2.4.4 Oxford BioMedica Product and Services
2.4.5 Oxford BioMedica Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.5 MolMed
2.5.1 MolMed Details
2.5.2 MolMed Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 MolMed SWOT Analysis
2.5.4 MolMed Product and Services
2.5.5 MolMed Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cobra Biologics
2.6.1 Cobra Biologics Details
2.6.2 Cobra Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cobra Biologics Product and Services
2.6.4 Cobra Biologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.7 Aldevron
2.7.1 Aldevron Details
2.7.2 Aldevron Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Aldevron Product and Services
2.7.4 Aldevron Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.8 BioReliance
2.8.1 BioReliance Details
2.8.2 BioReliance Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BioReliance Product and Services
2.8.4 BioReliance Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.9 Lonza
2.9.1 Lonza Details
2.9.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Lonza Product and Services
2.9.4 Lonza Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.10 UniQure
2.10.1 UniQure Details
2.10.2 UniQure Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 UniQure Product and Services
2.10.4 UniQure Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cell and Gene Therapy Catapult
2.11.1 Cell and Gene Therapy Catapult Details
2.11.2 Cell and Gene Therapy Catapult Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Cell and Gene Therapy Catapult Product and Services
2.11.4 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.12 VGXI
2.12.1 VGXI Details
2.12.2 VGXI Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 VGXI Product and Services
2.12.4 VGXI Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.13 Richter-Helm
2.13.1 Richter-Helm Details
2.13.2 Richter-Helm Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Richter-Helm Product and Services
2.13.4 Richter-Helm Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.14 PlasmidFactory
2.14.1 PlasmidFactory Details
2.14.2 PlasmidFactory Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 PlasmidFactory Product and Services
2.14.4 PlasmidFactory Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.15 MassBiologics
2.15.1 MassBiologics Details
2.15.2 MassBiologics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 MassBiologics Product and Services
2.15.4 MassBiologics Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.16 Yposkesi
2.16.1 Yposkesi Details
2.16.2 Yposkesi Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Yposkesi Product and Services
2.16.4 Yposkesi Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.17 Eurogentec
2.17.1 Eurogentec Details
2.17.2 Eurogentec Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Eurogentec Product and Services
2.17.4 Eurogentec Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.18 Gene Synthesis
2.18.1 Gene Synthesis Details
2.18.2 Gene Synthesis Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Gene Synthesis Product and Services
2.18.3 Gene Synthesis Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.19 Biovian
2.19.1 Biovian Details
2.19.2 Biovian Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Biovian Product and Services
2.19.4 Biovian Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.20 OBiO Technology
2.20.1 OBiO Technology Details
2.20.2 OBiO Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 OBiO Technology Product and Services
2.20.4 OBiO Technology Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
2.21 Jikai Gene
2.21.1 Jikai Gene Details
2.21.2 Jikai Gene Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Jikai Gene Product and Services
2.21.4 Jikai Gene Viral Vector and Plasmid DNA Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Viral Vector and Plasmid DNA Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Viral Vector and Plasmid DNA Players Market Share
3.2.2 Top 10 Viral Vector and Plasmid DNA Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Viral Vector and Plasmid DNA Revenue and Market Share by Regions
4.2 North America Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
4.3 Europe Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
4.5 South America Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
5 North America Viral Vector and Plasmid DNA Revenue by Countries
5.1 North America Viral Vector and Plasmid DNA Revenue by Countries (2015-2020)
5.2 USA Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
5.3 Canada Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
5.4 Mexico Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
6 Europe Viral Vector and Plasmid DNA Revenue by Countries
6.1 Europe Viral Vector and Plasmid DNA Revenue by Countries (2015-2020)
6.2 Germany Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
6.3 UK Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
6.4 France Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
6.5 Russia Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
6.6 Italy Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Viral Vector and Plasmid DNA Revenue by Countries
7.1 Asia-Pacific Viral Vector and Plasmid DNA Revenue by Countries (2015-2020)
7.2 China Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
7.3 Japan Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
7.4 Korea Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
7.5 India Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
8 South America Viral Vector and Plasmid DNA Revenue by Countries
8.1 South America Viral Vector and Plasmid DNA Revenue by Countries (2015-2020)
8.2 Brazil Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
8.3 Argentina Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Viral Vector and Plasmid DNA by Countries
9.1 Middle East & Africa Viral Vector and Plasmid DNA Revenue by Countries (2015-2020)
9.2 Saudi Arabia Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
9.3 UAE Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
9.4 Egypt Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
9.5 South Africa Viral Vector and Plasmid DNA Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Viral Vector and Plasmid DNA Revenue and Market Share by Type (2015-2020)
10.2 Global Viral Vector and Plasmid DNA Market Forecast by Type (2019-2024)
10.3 Plasmid DNA Revenue Growth Rate (2015-2025)
10.4 Viral Vector Revenue Growth Rate (2015-2025)
11 Global Viral Vector and Plasmid DNA Market Segment by Application
11.1 Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2015-2020)
11.2 Viral Vector and Plasmid DNA Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Virus Infection Revenue Growth (2015-2020)
11.5 Hereditary Disease Revenue Growth (2015-2020)
12 Global Viral Vector and Plasmid DNA Market Size Forecast (2021-2025)
12.1 Global Viral Vector and Plasmid DNA Market Size Forecast (2021-2025)
12.2 Global Viral Vector and Plasmid DNA Market Forecast by Regions (2021-2025)
12.3 North America Viral Vector and Plasmid DNA Revenue Market Forecast (2021-2025)
12.4 Europe Viral Vector and Plasmid DNA Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Viral Vector and Plasmid DNA Revenue Market Forecast (2021-2025)
12.6 South America Viral Vector and Plasmid DNA Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Viral Vector and Plasmid DNA Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

---